Yabao Pharmaceutical Group (600351.SH) plans to repurchase shares worth 100 million to 200 million yuan.
Yabao Pharmaceutical (600351.SH) announced that the company plans to repurchase shares worth between 100 million and 200 million yuan, with a repurchase price not exceeding 6.95 yuan per share. The repurchased shares will be entirely canceled in accordance with the law, and the company's registered capital will be reduced accordingly.
Yabao Pharmaceutical Group (600351.SH) announced that the company plans to repurchase shares worth 100 million to 200 million yuan, with the repurchase price not exceeding 6.95 yuan per share. The repurchased shares will be fully cancelled in accordance with the law, and the company's registered capital will be reduced accordingly.
Related Articles
HK Stock Market Move | LEGEND HOLDING (03396) rose over 6% following a positive earnings forecast, expecting a net profit attributable to equity holders in the first half to increase by no less than 186% year-on-year.
HK Stock Market Move | XUNCE (03317) surged over 18% as revenue driven by its token business significantly increased,.
HK Stock Market Move | TAI HING GROUP (06811) rose over 8% after announcing a profit alert, expecting a net profit attributable to shareholders of approximately HKD 72 million to HKD 78 million for the first half of the year.
HK Stock Market Move | LEGEND HOLDING (03396) rose over 6% following a positive earnings forecast, expecting a net profit attributable to equity holders in the first half to increase by no less than 186% year-on-year.
HK Stock Market Move | XUNCE (03317) surged over 18% as revenue driven by its token business significantly increased,.
HK Stock Market Move | TAI HING GROUP (06811) rose over 8% after announcing a profit alert, expecting a net profit attributable to shareholders of approximately HKD 72 million to HKD 78 million for the first half of the year.
RECOMMEND
